Charts Gain Therapeutics, Inc.

Stocks

Delayed Nasdaq 16:00:00 2026-10-26 EDT			5-day change	1st Jan Change
1.150 ^USD	-8.73%		-8.00%	-64.29%

10-01	Gain Therapeutics, Inc. Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence Of Disease-Modifying Activity Through 12 Months Administration	CI
09-28	Gain Therapeutics, Inc. Announces Executive Changes	CI

NasdaqUSD

Markets		Quality
Nasdaq	GANX	Delayed
CBOE	GANX	Real-time

ProRealTime Chart